Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013221 · ClinicalTrials.gov registry record · Phase 4

Exercise Effect on Aerobic Capacity and QOL in Heart Failure

A Phase 4 study of Heart Failure, Congestive, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 4
Development phase
84
Enrollment target
1
Study location

NCT00013221 is a Phase 4 study of Heart Failure, Congestive that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 84 participants, below the 639-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013221, a Phase 4 study of Heart Failure, Congestive, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 4
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Chronic heart failure (HF) is a syndrome of impaired ventricular function resulting in clinical symptoms of fatigue, dyspnea, and decreased exercise capacity. These symptoms lead to a cyclical pattern of an increasing sedentary lifestyle with accompanying deconditioning and deterioration of muscle function. Until recently, the prescription for individuals with HF was rest and minimization of physical exertion.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

Illinois

  • Edward Hines Jr. VA Hospital, Hines, IL - Hines

Trial Details

FieldValue
Enrollment Target 84 participants
Est. Completion 2000-03
Phase Phase 4

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00013221

The ClinicalTrials.gov registry entry for NCT00013221 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 639-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (87% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT00013221 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00013221 about?

NCT00013221 is a clinical study titled "Exercise Effect on Aerobic Capacity and QOL in Heart Failure". Chronic heart failure (HF) is a syndrome of impaired ventricular function resulting in clinical symptoms of fatigue, dyspnea, and decreased exercise capacity. These symptoms lead to a cyclical pattern of an increasing sedentary lifestyle with accompanying deconditioning and deterioration of muscle f...

What is the current status of trial NCT00013221?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. Estimated completion is 2000-03.

What conditions does trial NCT00013221 study?

This clinical trial studies the following conditions: Heart Failure, Congestive.

What interventions are being tested in trial NCT00013221?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013221?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00013221 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure, Congestive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.